PerkinElmer Completes Acquisition of Packard BioScience | GenomeWeb

NEW YORK, Nov. 13 – PerkinElmer has completed its acquisition of Packard BioScience, the company announced on Tuesday.

Packard will be integrated into PerkinElmer’s life-science unit, which will be led by John J. Engel, president of the division and executive vice resident of PerkinElmer, according to a statement.

Frank Witney, formerly president of Packard BioScience, has become president of drug discovery. He will report to Engel, PerkinElmer said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."